Thursday, April 24, 2025 | 11 AM ET
Presented by
Bashoo Naziruddin, PhD
Total pancreatectomy with islet autotransplantation (TPIAT) is the preferred treatment for patients with refractory chronic pancreatitis (CP) who fail to respond to other medical interventions. This procedure is primarily performed to relieve pain, improve quality of life and retain pancreatic endocrine function to prevent type 3c diabetes. The procedure to isolate islets from the inflamed pancreatic tissue due to CP is essentially similar to the method followed for normal pancreas obtained from deceased organ donors. However, the yield of high-quality islets from CP patients varies dramatically from normal pancreas.
This presentation will highlight the recent progress made by our team in the field of TPIAT with emphasis on identification of biomarkers for prediction of good islet yield from the inflamed pancreas and favorable endocrine function during post-transplant period.
The webinar will use the Zoom meeting platform and not the webinar platform. This will enable direct communication between the meeting participants. The total number of participants at this meeting will be limited to 100 individuals.
Download Presentation Slides
Auto Subscribe to Webinars
If you would like to be automatically subscribed to all future webinars, please submit your email below.
Meet the Presenter
Bashoo Naziruddin, PhD
Bashoo.Naziruddin@BSWHealth.org
Bashoo Naziruddin, PhD, is the Director of the islet cell processing laboratory at Baylor University Medical Center in Dallas since April 2003. He is also an Adjunct Professor at the Institute of Biomedical Studies at Baylor University, Waco, Texas. He graduated with a PhD in Biochemistry from the University of Madras, India and has been active in biological research at several institutions in the USA since 1987. He has worked in academic institutions, the biotech industry and health care systems. Recently he was elected as a fellow of the American Society of Transplantation (FAST).
He is currently leading the team that performs pancreatic islet cell transplants into type 1 diabetics and chronic pancreatitis patients. He has published >180 manuscripts in peer-reviewed journals and presented more than 200 abstracts at international and national scientific meetings. He is a mentor for PhD students and post-doctoral fellows. He has successfully received grants from the National Institutes of Health, Breakthrough T1D, American Heart Association and other intramural sources. He has delivered invited talks at reputable academic institutions. He has served as the chairperson of scientific sessions at international and national research meetings. He is a reviewer for several scientific journals in the field of immunology and transplantation. His current research is focused on improving the clinical outcomes of human islet transplantation and understanding the immune response against islet cells.